MedPath

Budesonide

These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION.BUDESONIDE INHALATION SUSPENSION.Initial U.S. Approval: 2000

Approved
Approval ID

d9656442-4587-4867-9a8c-5f5b0402936e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 11, 2020

Manufacturers
FDA

Exelan Pharmaceuticals, Inc.

DUNS: 967795266

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Budesonide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76282-640
Application NumberANDA205710
Product Classification
M
Marketing Category
C73584
G
Generic Name
Budesonide
Product Specifications
Route of AdministrationORAL
Effective DateDecember 11, 2020
FDA Product Classification

INGREDIENTS (6)

BUDESONIDEActive
Quantity: 0.25 mg in 2 mL
Code: Q3OKS62Q6X
Classification: ACTIB
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT

Budesonide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76282-641
Application NumberANDA205710
Product Classification
M
Marketing Category
C73584
G
Generic Name
Budesonide
Product Specifications
Route of AdministrationORAL
Effective DateDecember 11, 2020
FDA Product Classification

INGREDIENTS (6)

POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
BUDESONIDEActive
Quantity: 0.5 mg in 2 mL
Code: Q3OKS62Q6X
Classification: ACTIB
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT

Budesonide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76282-642
Application NumberANDA205710
Product Classification
M
Marketing Category
C73584
G
Generic Name
Budesonide
Product Specifications
Route of AdministrationORAL
Effective DateDecember 11, 2020
FDA Product Classification

INGREDIENTS (6)

BUDESONIDEActive
Quantity: 1 mg in 2 mL
Code: Q3OKS62Q6X
Classification: ACTIB
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Budesonide - FDA Drug Approval Details